Buys | $20,000,500 | 1 | 100 |
Sells | $0 | 0 | 0 |
PERCEPTIVE ADVISORS LLC | 10 percent owner | 1 | $20M | 0 | $0 | $20M |
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate …
Over the last 12 months, insiders at Acrivon Therapeutics, Inc. Common Stock have bought $20M and sold $0 worth of Acrivon Therapeutics, Inc. Common Stock stock.
On average, over the past 5 years, insiders at Acrivon Therapeutics, Inc. Common Stock have bought $33.68M and sold $97,579 worth of stock each year.
Highest buying activity among insiders over the last 12 months: PERCEPTIVE ADVISORS LLC (10 percent owner) — $20M.
The last purchase of 2,353,000 shares for transaction amount of $20M was made by PERCEPTIVE ADVISORS LLC (10 percent owner) on 2024‑04‑11.
2024-04-11 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 2.35M 8.4743% | $8.50 | $20M | -21.10% | ||
2023-06-26 | Sale | Chione Ltd | 10 percent owner | 16 <0.0001% | $12.93 | $207 | -48.66% | |
2023-06-15 | Sale | Chione Ltd | 10 percent owner | 2,056 0.0106% | $12.14 | $24,960 | -39.33% | |
2023-06-14 | Sale | Chione Ltd | 10 percent owner | 893 0.0046% | $12.13 | $10,832 | -38.40% | |
2023-06-13 | Sale | Chione Ltd | 10 percent owner | 3,000 0.0156% | $12.30 | $36,900 | -40.28% | |
2023-06-12 | Sale | Chione Ltd | 10 percent owner | 2,000 0.0105% | $12.34 | $24,680 | -40.91% | |
2022-11-17 | RA CAPITAL MANAGEMENT, L.P. | 3.39M 17.9519% | $12.50 | $42.37M | -21.95% | |||
2022-11-17 | Chione Ltd | 10 percent owner | 400,000 2.1185% | $12.50 | $5M | -21.95% |
PERCEPTIVE ADVISORS LLC | 10 percent owner | 5360858 17.2174% | $29.16M | 1 | 0 | |
RA CAPITAL MANAGEMENT, L.P. | 4384206 14.0807% | $23.85M | 1 | 0 | <0.0001% | |
Chione Ltd | 10 percent owner | 3848632 12.3606% | $20.94M | 1 | 5 | <0.0001% |
$2,924,567 | 72 | -4.87% | $157.74M | |
$613,304,943 | 46 | 11.85% | $191.55M | |
$79,019,806 | 27 | 7.24% | $165.26M | |
$6,915,275 | 21 | -32.61% | $158.47M | |
$2,484,989 | 17 | -17.86% | $156.9M |
Increased Positions | 30 | +53.57% | 752,160 | +3.28% |
Decreased Positions | 20 | -35.71% | 479,087 | -2.09% |
New Positions | 12 | New | 443,594 | New |
Sold Out Positions | 6 | Sold Out | 200,370 | Sold Out |
Total Postitions | 66 | +17.86% | 23M | +1.19% |
Ra Capital Management, L.P. | $44,288.00 | 26.91% | 8.34M | 0 | 0% | 2024-12-31 |
Perceptive Advisors Llc | $28,466.00 | 17.29% | 5.36M | 0 | 0% | 2024-12-31 |
Sands Capital Ventures, Llc | $11,271.00 | 6.85% | 2.12M | 0 | 0% | 2024-12-31 |
Citadel Advisors Llc | $11,255.00 | 6.84% | 2.12M | -20,982 | -0.98% | 2024-12-31 |
Blackrock, Inc. | $5,021.00 | 3.05% | 945,496 | +158,514 | +20.14% | 2024-12-31 |
Wellington Management Group Llp | $4,716.00 | 2.87% | 888,130 | 0 | 0% | 2024-12-31 |
Vanguard Group Inc | $3,566.00 | 2.17% | 671,625 | +34,087 | +5.35% | 2024-12-31 |
Marshall Wace, Llp | $3,174.00 | 1.93% | 597,794 | -212,065 | -26.18% | 2024-12-31 |
Acorn Capital Advisors, Llc | $2,152.00 | 1.31% | 405,237 | +405,237 | New | 2024-12-31 |
Geode Capital Management, Llc | $1,600.00 | 0.97% | 301,389 | -714 | -0.24% | 2024-12-31 |